DNA · Company research
Ginkgo Bioworks Holdings, Inc. (DNA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand - Yahoo Finance | Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market | Ginkgo Bioworks Holdings (DNA) declined 1.96% to $11.53, underperforming the S&P 500's 1.11% loss on October 14, 2026. Despite a strong 68.24% monthly gain, the company faces headwinds with expected EPS of -$0.58 and revenue projected to decline 47.22% quarter-over-quarter. Full-year estimates show -$3.2 EPS and 51.69% revenue decline. The stock holds a Zacks Rank #3 (Hold) rating with unchanged consensus estimates over the past 30 days. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bearish | -1 | 1 |
| Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - Yahoo Finance | Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street | Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 13, 2026 | neutral | 0 | 0.6 |
| $DNA stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $DNA stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 12, 2026 | neutral | 0 | 0.6 |
| DNA Nov 2027 3.000 put (DNA271119P00003000) Stock Price, News, Quote & History - Yahoo! Finance Canada | DNA Nov 2027 3.000 put (DNA271119P00003000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| An imaging system captures a plate of 1,536 tiny wells in under four minutes at Ginkgo's Boston lab. - Stock Titan | An imaging system captures a plate of 1,536 tiny wells in under four minutes at Ginkgo's Boston lab. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know | Ginkgo Bioworks (DNA) declined 7.57% in recent trading, significantly underperforming the broader market. The stock has gained 78.82% over the past month but faces headwinds with projected earnings of -$0.58 per share and a 47.22% revenue decline expected. The company holds a Zacks Rank of #3 (Hold), with its industry ranking in the bottom 28% of all sectors. | View source ↗ | Zacks Investment Research | Oct 7, 2026 | bearish | -1 | 1 |
| Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know | Ginkgo Bioworks (DNA) declined 7.57% in recent trading, significantly underperforming the broader market. The stock has gained 78.82% over the past month but faces headwinds with projected earnings of -$0.58 per share and a 47.22% revenue decline expected. The company holds a Zacks Rank of #3 (Hold), with its industry ranking in the bottom 28% of all sectors. | View source ↗ | Zacks Investment Research | Oct 7, 2026 | bearish | -1 | 1 |
| A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan | A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks: The Valuation Has Outrun The Business (NYSE:DNA) - Seeking Alpha | Ginkgo Bioworks: The Valuation Has Outrun The Business (NYSE:DNA) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 7, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (DNA) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (DNA) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 6, 2026 | neutral | 0 | 0.6 |
| Officer Steven P. Coen proposes selling 2,403 Ginkgo Bioworks (NYSE: DNA) shares. - Stock Titan | Officer Steven P. Coen proposes selling 2,403 Ginkgo Bioworks (NYSE: DNA) shares. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance | Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 1, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance | Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? - Yahoo Finance | Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 18, 2026 | neutral | 0 | 0.6 |
| $DNA stock is up 12% today. Here's what we see in our data. - Quiver Quantitative | $DNA stock is up 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks (NYSE: DNA) insider plans 2,200-share sale - Stock Titan | Ginkgo Bioworks (NYSE: DNA) insider plans 2,200-share sale Stock Titan | View source ↗ | Stock Titan | Aug 17, 2026 | neutral | 0 | 0.6 |
| Ginkgo Bioworks (DNA) Stock Falls on Q2 2026 Earnings - Quiver Quantitative | Ginkgo Bioworks (DNA) Stock Falls on Q2 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 5, 2026 | neutral | 0 | 0.6 |
| $DNA stock is up 18% today. Here's what we see in our data. | DNA Stock News - Quiver Quantitative | $DNA stock is up 18% today. Here's what we see in our data. | DNA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.